
Superb study published in @CircAHA. First RCT in PE in more than a decade. Big step forward!

Hematologist @massgeneralnews

Superb study published in @CircAHA. First RCT in PE in more than a decade. Big step forward!

@RosovskyRachel Presents STORM-PE RCT Results at VIVA 2025 @PERTConsortium @roblookstein | @Angiologist hemostasistoday.com/voices/r… #Anticoagulation #DeepVenousThrombosis #DVT #Health #Hematology #Hemostasis #STORM_PE #HemostasisToday #Medicine #PERTConsortium #VIVA2025 #PulmonaryEmbolism #Thrombosis #VenousThrombosis #MedEd #MedX

#JustPublished: STORM-PE RCT Primary Outcomes @roblookstein @RosovskyRachel @sahilparikhmd @angiologist @KNagarshethMD ahajrnls.org/47EvaEU

Thank you @Pertconsortium for partnering with Penumbra on this trial.
Another incredible moment for PE-Storm at #VIVA25! Honored to have partnered with @PenumbraInc on this groundbreaking trial—paving the way for new standards in pulmonary embolism treatment and outcomes. Congratulations @RosovskyRachel @roblookstein

Breaking news! @RosovskyRachel announced the PE- Storm Trial first and secondary results just published.


Thrilled on behalf of all the STORM-PE investigators and patients to share these groundbreaking results. Thank you Circ for simultaneous publication: ahajournals.org/doi/10.1161/…
STORM-PE shows improved functional outcomes for mechanical thrombectomy at discharge and at 90 days @VIVAPhysicians #VIVA25

Thank you Circ for simultaneous publication:ahajournals.org/doi/10.1161/…
Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Signific... prn.to/4qYWMOb

Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Signific... prn.to/4qYWMOb

Thank you VIVA and honored to present our late breaking abstract, STORM-PE 90 days results showing earlier physiological recovery and improvement in 90 day functional status with MT + AC vs AC alone in intermediate high risk PE pts. Thank you Circ for simultaneous publication. #VIVA2025 @PERTConsortium
This tweet is unavailable

Live @TCTConference @crfheart amazing session today discussing the impact of the #STORM-PE data on the future of #PE care. Thank you @PenVascular for the support of the study.

Patients with acute intermediate-high-risk PE who undergo mechanical thrombectomy have a greater reduction in the RV/LV ratio at 48 hours than those treated with anticoagulation alone, according to results from the first-of-its-kind STORM-PE RCT. #TCT2025 tctmd.com/news/mechanical-th…

The first—and only—RCT proving anticoagulation (AC) works for PE was in 1960 with 73 patients. See how far we've come. At #VIVA2025, on behalf of #STORMPE team & in collaboration #PERTConsortium, I’ll present the first RCT comparing MT + AC vs AC alone for acute intermediate–high-risk PE. @PERTConsortium @roblookstein @stavroskonstan7 @IdoWeinberg @rchannick @sahilparikhmd johnmoriarty suhaildohad richarddavis

Live @TCTConference First podium presentation of the #STORM-PE trial!! First RCT of thrombectomy vs Anticoag ever!! Thank you to @crfheart @PenVascular @PERTConsortium for advancing the field

Join us in San Diego for the PERT Consortium 2025 Scientific Symposium. Learn and network with experts from all over the world.
Only 3 days left in the PERT 2025 Registration Summer Sale! ☀️Save $100 on PERT 2025 Registration by using code SUMMER100 (Valid 5/23 - 5/30 only) Register now: pertconsortium.org/attendee-…

We want to learn from you! How do you evaluate heavy menstrual bleeding in patients on anticoagulation. Take our survey: redcap.link/f8v5m0si @CardioNerds @isth @ASH_hematology @PERTConsortium @thrombosisday @acweyand @bhwords @aswolberg @fnainle
How do you as a medical provider evaluate heavy menstrual bleeding in patients on anticoagulation? Foundation for Women & Girls w/Blood Disorders is interested in identifying ways to improve care for patients with menorrhagia through research survey. redcap.link/f8v5m0si